These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 5973163)
21. Mechanism of action of chromomycin A3. II. Inhibition of RNA polymerase reaction. Kajiro Y; Kamiyama M J Biochem; 1967 Oct; 62(4):424-9. PubMed ID: 5587590 [No Abstract] [Full Text] [Related]
22. The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. Obrig TG; Culp WJ; McKeehan WL; Hardesty B J Biol Chem; 1971 Jan; 246(1):174-81. PubMed ID: 5541758 [No Abstract] [Full Text] [Related]
23. The studies on the chemical derivations of formycin and formycin B. Watanabe S; Matsuhashi G; Fukatsu S; Koyama G; Maeda K; Umezawa H J Antibiot (Tokyo); 1966 Mar; 19(2):93-6. PubMed ID: 5952900 [No Abstract] [Full Text] [Related]
24. Actinomycin and antitumor antibiotics. Young CW Am J Clin Pathol; 1969 Aug; 52(2):130-7. PubMed ID: 5798361 [No Abstract] [Full Text] [Related]
25. Topochemical approach in studies of the structure-activity relation: enantio-enniatin B. Shenyakin MM; Ovchinnikov YA; Ivanov VT; Evstratov AV Nature; 1967 Jan; 213(5074):412-3. PubMed ID: 4961750 [No Abstract] [Full Text] [Related]
26. [Study on the alkaline hydrolysis of alpha-ethyl-alpha-phenyl glutarimide]. Dorlet C J Pharm Belg; 1969; 24(11):509-20. PubMed ID: 5371752 [No Abstract] [Full Text] [Related]
27. Inomycin a new antibiotic of the cycloheximide group. I. Characteristics of the strain and antibiotic production. Tyc M Arch Immunol Ther Exp (Warsz); 1970; 18(1):117-28. PubMed ID: 4908939 [No Abstract] [Full Text] [Related]
28. PROTOMYCIN, A NEW ANTIBIOTIC OF CYCLOHEXIMIDE GROUP. III. DEGRADATION PRODUCTS. SUGAWARA R J Antibiot (Tokyo); 1963 Jul; 16():167-71. PubMed ID: 14044932 [No Abstract] [Full Text] [Related]
29. Inhibition of DNA synthesis by cycloheximide and blasticidin-S is independent of their effect on protein synthesis. Sullia SB; Griffin DH Biochim Biophys Acta; 1977 Mar; 475(1):14-22. PubMed ID: 849443 [TBL] [Abstract][Full Text] [Related]
30. Mutagenicity in yeast of nitroquinolines and related compounds. Epstein SS; Pierre JA Toxicol Appl Pharmacol; 1969 Sep; 15(2):451-60. PubMed ID: 5804756 [No Abstract] [Full Text] [Related]
31. [The genetic effect of aromatic amines and their derivatives: induction of mytotic conversion in the yeast Saccharomyces cerevisiae]. Marquardt H; Zimmermann FK; Dannenberg H; Neumann HG; Bodenberger A; Metzler M Z Krebsforsch; 1970; 74(4):412-33. PubMed ID: 4253314 [No Abstract] [Full Text] [Related]
32. [Antibacterial and antineoplastic antibiotics]. Gol'dberg LE Sov Med; 1977 Oct; (10):115-23. PubMed ID: 201038 [No Abstract] [Full Text] [Related]
33. Chemical mutagens as a possible genetic hazard in human populations. Malling HV Am Ind Hyg Assoc J; 1970; 31(6):657-66. PubMed ID: 4924286 [No Abstract] [Full Text] [Related]
34. [Standardization of the diffusion method of determining the biological activity of polyene antibiotics]. Vasil'eva NG; Fradkova TA; Bershteĭn EM; Golubkova LS; Poliak MS Tr Inst Im Pastera; 1982; 58():117-9. PubMed ID: 7187546 [No Abstract] [Full Text] [Related]
35. Morphological changes and resistance induced in Saccharomyces pastorianus by the antibiotic cycloheximide. GUNDERSEN K; WADSTEIN T J Gen Microbiol; 1962 Jun; 28():325-32. PubMed ID: 13902947 [No Abstract] [Full Text] [Related]
36. Recent developments of antibiotic research and classification of antibiotics according to chemical structure. Bérdy J Adv Appl Microbiol; 1974; 18(0):309-406. PubMed ID: 4613148 [No Abstract] [Full Text] [Related]
37. Aurafuron A and B, new bioactive polyketides from Stigmatella aurantiaca and Archangium gephyra (Myxobacteria). Fermentation, isolation, physico-chemical properties, structure and biological activity. Kunze B; Reichenbach H; Müller R; Höfle G J Antibiot (Tokyo); 2005 Apr; 58(4):244-51. PubMed ID: 15981410 [TBL] [Abstract][Full Text] [Related]
38. [Effectiveness of the use of Staphylococcus aureus 209 mutant UV-2 at different stages of screening of new antineoplastic antibiotics]. Kochetkova GV; Il'chenko GB; Kovsharova IN Antibiotiki; 1970 Jul; 15(7):587-90. PubMed ID: 4097990 [No Abstract] [Full Text] [Related]
39. [The effect of various cytostatic drugs on the growth of 12 chosen mycobacterial strains]. Schwartz E Prax Pneumol; 1971 May; 25(5):278-86. PubMed ID: 5556356 [No Abstract] [Full Text] [Related]
40. [Experimental study of the antimicrobial properties and antineoplastic effect of the new pentaenic antibiotic 661]. Rossolimo OK; Ivanitskaia LP; Kovsharova IN; Konstantinova NV; Lavrova MF Antibiotiki; 1969 Sep; 14(9):849-52. PubMed ID: 4982966 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]